Thus, the aims of the current study were to examine the role of SP in tumor-associated edema in a model of brain tumors secondary to melanoma, and to establish whether NK1 antagonists may provide a novel alternative treatment to brain tumor edema. The gene discussed is TFF2; the disease is brain neoplasm.